| Speakers from |
 |
Pfizer
N.V. Organon
Bristol Myers Squibb Company
Astra Zeneca
Novartis Pharma AG
Bayer Healthcare
F. Hoffmann-La Roche
Boehringer Ingelheim Germany Schering AG |
|
|
|
|
| Featured Speakers |
|
|
|
Iman El-Hariry,
Group Director, Oncology MDC, Europe, GlaxoSmithKline R&D
|
 |
|
|
Dorothee Foernzler,
Biomarker - Experimental Medicine Leader F.Hoffmann-La Roche
|
|
|
|
Stuart Freeman,
Director of Worldwide Toxicology, GlaxoSmithKline UK
|
|
|
|
Nicolas Frey,
Head of the Modeling and Simulation Group, F. Hoffmann-La Roche
|
|
|
|
William Gallagher,
Associate Professor, University College Dublin
|
|
|
|
Antony Gee,
Head of PET and Radiotracer Development, GlaxoSmithKline
|
|
|
|
Martin Grigorov,
Head of Bioinformatics, Nestle Research Centre
|
|
|
|
Ehud Hauben,
Head of Molecular Medicine Unit, Clinical Sciences and Biomarkers, Exploratory Medicine, Merck Serono Research
|
|
|
|
Hermann-Josef Huss,
Head, Data Acquisition & Management Europe & Overseas, Bayer Healthcare
|
|
|
|
Jeanne Kehren,
Head of Integrated Analysis, Biomarker Development, Novartis Pharma AG
|
|
|
|
Bernard Leblanc,
Head, Regulatory Submissions & External Relations Safety Sciences, Pfizer
|
|
|
|
Ruth March,
Personalized Healthcare Science & Technology Director, Personalized Healthcare Team, Astra Zeneca UK
|
|
|
|
Dario Neri,
Professor, Department of Chemistry and Applied Biosciences ETH Zurich
|
|
|
|
Martin Oleksiewicz,
Team Leader, Molecular Toxicology, Novo Nordisk A/S
|
|
|
|
Koustubh Ranade,
Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company
|
|
|
|
Bjorn Riefke,
Head Laboratory Diagnostics Non-Clinical Drug Safety, Bayer Healthcare
|
|
|
|
Ronenn Roubenoff,
MD, Senior Director, Immunology Medical Research, Biogen Idec, Inc.
|
|
|
|
Hugh Salter,
Associate Director, Pharmacogenomics, Astra Zeneca
|
|
|
|
Michael Shi,
Director and Biomarker Project Leader of Exploratory Oncology Development, Novartis
|
|
|
|
Magnus Sjogren,
Associate Professor, Psychiatrist, Director Clinical Research CNS, N.V. Organon
|
|
|
|
Thomas Steger-Hartmann,
Head Lab Diagnostics Experimental Toxicology, Schering AG
|
|
|
|
Detlef Stiller,
Head, Invivo Imaging, Boehringer Ingelheim Germany
|
|
|
|
Stefan Sultana,
Translational Medicine Leader for GU Therapeutic Area, Pfizer
|
|
|
|
Jean Tessier,
Clinical Imaging Scientist, Discovery Medicine, Astra Zeneca
|
|
|
|
Alain van Gool,
Director Genomics & Proteomics N.V. Organon
|
|
|
|
George Wensing,
Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare
|
|
|
|
Paul Whiting,
Head of Biomarkers and Translational Biology, Discovery Biology, Pfizer
|
|
|
|
|
|
